Last week, President Donald J. Trump sent letters to 17 of the leading pharmaceutical companies outlining steps they must take to lower prescription ...

Analysis by GlobalData characterises an uncertain pharma landscape, though big pharma CEOs allay investor concern.

In an earnings call on July 29th, in which the company reported a 13% increase in half-year profits, he said about Britain ...

It plans to invest $50 billion in the US over five years, including building its largest-ever manufacturing facility in ...

AstraZeneca already sells 40 per cent of its drugs to America and, following President Donald Trump 's tariff threat, is ...

Donald Trump has sacked America’s top statistician after official data showed a sharp slowdown in the US jobs market. The US ...

Pharmaceutical stocks across the global markets have taken a hit after Trump demanded drug companies lower prices for ...

France's CAC 40 fell 1.8%, and Germany's DAX dropped 1.7%, underlining the significant impact the new measures are having across Europe's largest economies.

Inflation in the US is rising and likely to rise further, but the American economy is growing regardless - seemingly ...

A fresh ultimatum demanding "binding commitments" to lower U.S. drug prices sent pharma firms scrambling Friday.

The announcement of a 15% tariff on pharmaceutical imports to the U.S. from the European Union may have not been the ideal ...

In the letters, sent to Eli Lilly & Co., Novo Nordisk A/S, Pfizer Inc. and others, Trump insisted companies immediately lower ...